Digital Biotechnology – Research, clinical development, adoption in medical practice

The event – divided into 2 parts, held over 2 consecutive mornings – examines 2 of the major critical issues of Digital Biotechnology, namely Advanced ATMP Therapies and Digital Therapies: (1) clinical development and the level of efficacy tests necessary to allow authorization use and access to reimbursement (2) the methods of access to medical practice. For each part, some introductory talks will be held, followed by a round table and debate with the public.